Sanofi Stock Quote 1SAN - Stock Price, News, Charts, Message Board, Trades

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

92.63

Bid

92.42

Ask

92.49

Volume

250

92.29 Day's Range 92.85

84.98 52 Week Range 107.96

Market Cap

116.032B

Previous Close

91.96

Open

92.29

Last Trade

92.63

Last Trade Time

08:33:46

Financial Volume

VWAP

Average Volume (3m)

808

Shares Outstanding

1,252,640,466

Dividend Yield

4.06%

PE Ratio

21.45

Earnings Per Share (EPS)

4.31

Revenue

43.07B

Net Profit

5.4B

Sector

Health & Allied Services,nec

Industry

Pharmaceutical Preparations

Website

www.sanofi.com

Headquarters

Paris, Paris, Fra

Founded

1994

Sanofi is listed in the Health & Allied Services sector of the Italian Stock Exchange with ticker 1SAN. The last closing price for Sanofi was 91.96 €. Over the last year, Sanofi shares have traded in a share price range of 84.98 € to 107.96 €.

Sanofi currently has 1,252,640,466 shares outstanding. The market capitalization of Sanofi is 115.19 € billion. Sanofi has a price to earnings ratio (PE ratio) of 21.45.

Communiqué de presse : Sanofi lance un programme de phase III pour son vaccin VPC21 et élargit sa collaboration avec SK Bioscience afin de développer une nouvelle génération de vaccins pneumococciques conjugués

Communiqué de presse : Sanofi lance un programme de phase III pour son vaccin VPC21 et élargit sa collaboration avec SK Bioscience afin de développer une nouvelle génération de vaccins...

Press Release: Sanofi initiates phase 3 program for PCV21 and expands collaboration with SK bioscience for next-generation pneumococcal conjugate vaccines

Press Release: Sanofi initiates phase 3 program for PCV21 and expands collaboration with SK bioscience for next-generation pneumococcal conjugate vaccines Sanofi initiates phase 3 program for...

Communiqué de presse - Jean-Paul Kress rejoint le Conseil d’administration de Sanofi

Communiqué de presse - Jean-Paul Kress rejoint le Conseil d’administration de Sanofi Jean-Paul Kress rejoint le Conseil d’administration de Sanofi Paris, le 19 décembre 2024. Le Conseil...

Presse release: Jean-Paul Kress to join Sanofi's Board of Directors

Presse release: Jean-Paul Kress to join Sanofi's Board of Directors Jean-Paul Kress to join Sanofi's Board of Directors Paris, December 19, 2024. Sanofi's Board of Directors is pleased to...

Press Release: Duvakitug positive phase 2b results demonstrate best-in-class potential in ulcerative colitis and Crohn’s disease

Press Release: Duvakitug positive phase 2b results demonstrate best-in-class potential in ulcerative colitis and Crohn’s disease Duvakitug positive phase 2b results demonstrate best-in-class...

Communiqué de presse : Les résultats positifs de phase IIb concernant le duvakitug illustrent son potentiel de meilleur médicament de sa catégorie pour le traitement de la colite ulcéreuse et de la maladie de Crohn

Communiqué de presse : Les résultats positifs de phase IIb concernant le duvakitug illustrent son potentiel de meilleur médicament de sa catégorie pour le traitement de la colite ulcéreuse et de...

Press Release: Availability of the Q4 2024 Aide-mémoire

Press Release: Availability of the Q4 2024 Aide-mémoire Availability of the Q4 2024 Aide-mémoire Paris, France – December 17, 2024. Sanofi announced today that its Q4 2024 Aide-mémoire is...

Communiqué de presse : Mise en ligne du document « Q4 2024 Aide-mémoire »

Communiqué de presse : Mise en ligne du document « Q4 2024 Aide-mémoire » Mise en ligne du document « Q4 2024 Aide-mémoire » Paris, France, le 17 Décembre 2024. Sanofi annonce la mise en ligne...

Communiqué de presse : Le tolebrutinib obtient la désignation de « Médicament innovant » de la FDA pour le traitement de la sclérose en plaques secondairement progressive sans poussées

Communiqué de presse : Le tolebrutinib obtient la désignation de « Médicament innovant » de la FDA pour le traitement de la sclérose en plaques secondairement progressive sans poussées Le...

Press Release: Tolebrutinib designated Breakthrough Therapy by the FDA for non-relapsing secondary progressive multiple sclerosis

Press Release: Tolebrutinib designated Breakthrough Therapy by the FDA for non-relapsing secondary progressive multiple sclerosis Tolebrutinib designated Breakthrough Therapy by the FDA for...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	1.99	2.19549867608	90.64	92.85	89.92	1586	91.70061495	DE
4	0.77	0.838232092314	91.86	93.79	87.48	1102	91.28885911	DE
12	-8.93	-8.79283182355	101.56	101.68	87.48	808	94.15025227	DE
26	2.35	2.60301284891	90.28	107.96	87.48	889	96.15817409	DE
52	4.03	4.54853273138	88.6	107.96	84.98	851	93.14127388	DE
156	4.78	5.44109277177	87.85	107.96	76.36	976	91.6652387	DE
260	2.2	2.43282096649	90.43	107.96	68	1482	87.78671493	DE

1SAN - Frequently Asked Questions (FAQ)

What is the current Sanofi share price?

The current share price of Sanofi is 92.63 €

How many Sanofi shares are in issue?

Sanofi has 1,252,640,466 shares in issue

What is the market cap of Sanofi?

The market capitalisation of Sanofi is EUR 115.19B

What is the 1 year trading range for Sanofi share price?

Sanofi has traded in the range of 84.98 € to 107.96 € during the past year

What is the PE ratio of Sanofi?

The price to earnings ratio of Sanofi is 21.45

What is the cash to sales ratio of Sanofi?

The cash to sales ratio of Sanofi is 2.69

What is the reporting currency for Sanofi?

Sanofi reports financial results in EUR

What is the latest annual turnover for Sanofi?

The latest annual turnover of Sanofi is EUR 43.07B

What is the latest annual profit for Sanofi?

The latest annual profit of Sanofi is EUR 5.4B

What is the registered address of Sanofi?

The registered address for Sanofi is 46, AVENUE DE LA GRANDE ARMEE, PARIS, PARIS, 75017

What is the Sanofi website address?

The website address for Sanofi is www.sanofi.com

Which industry sector does Sanofi operate in?

Sanofi operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
WELESEles Spa	0.1289 € (28.77%)	25.8k
MNLMonnalisa SPA	1.41 € (15.57%)	183.65k
BIROEstrima Spa	0.26 € (14.04%)	153.2k
FDAFidia	0.0408 € (13.33%)	3.53M
DGVDigital Value Spa	24.60 € (11.56%)	132.52k
WTFINTrevi Finanziaria Industriale Spa	0.841 € (-20.74%)	100
WS3D25Solid World Group spa	0.20 € (-16.25%)	71k
1KGXKion Group AG	31.83 € (-11.34%)	7
WPOZ27Pozzi Milano Spa	0.09 € (-9.37%)	10k
PREPredict SpA	0.632 € (-7.06%)	4.5k
TITTelecom Italia SpA	0.2446 € (1.07%)	88.71M
ISPIntesa Sanpaolo Spa	3.858 € (0.99%)	24.03M
TITRTelecom Italia	0.2859 € (1.02%)	13.99M
SPMSaipem Spa	2.511 € (1.17%)	10.7M
ENELEnel Spa	6.782 € (-0.25%)	9.04M